MA26545A1 - Procedes de cicatrisation des os - Google Patents

Procedes de cicatrisation des os

Info

Publication number
MA26545A1
MA26545A1 MA25247A MA25247A MA26545A1 MA 26545 A1 MA26545 A1 MA 26545A1 MA 25247 A MA25247 A MA 25247A MA 25247 A MA25247 A MA 25247A MA 26545 A1 MA26545 A1 MA 26545A1
Authority
MA
Morocco
Prior art keywords
bone healing
healing processes
processes
bone
healing
Prior art date
Application number
MA25247A
Other languages
English (en)
Inventor
Henry Vickery Brian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26545A1 publication Critical patent/MA26545A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
MA25247A 1997-09-09 1998-09-08 Procedes de cicatrisation des os MA26545A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5832497P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
MA26545A1 true MA26545A1 (fr) 2004-12-20

Family

ID=22016113

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25247A MA26545A1 (fr) 1997-09-09 1998-09-08 Procedes de cicatrisation des os

Country Status (32)

Country Link
US (1) US6583114B2 (fr)
EP (1) EP1005359B1 (fr)
JP (1) JP2002509854A (fr)
KR (1) KR100679778B1 (fr)
CN (1) CN1210059C (fr)
AR (1) AR015435A1 (fr)
AT (1) ATE297754T1 (fr)
AU (1) AU752925B2 (fr)
BR (1) BR9812068A (fr)
CA (1) CA2302255C (fr)
CO (1) CO4890856A1 (fr)
CZ (1) CZ298701B6 (fr)
DE (1) DE69830591T2 (fr)
ES (1) ES2244090T3 (fr)
HK (1) HK1030753A1 (fr)
HR (1) HRP20000109A2 (fr)
HU (1) HU226866B1 (fr)
IL (2) IL134719A0 (fr)
MA (1) MA26545A1 (fr)
MY (1) MY121291A (fr)
NO (1) NO323740B1 (fr)
NZ (1) NZ502970A (fr)
PE (1) PE117399A1 (fr)
PL (1) PL195703B1 (fr)
RS (1) RS49707B (fr)
RU (1) RU2224539C2 (fr)
SA (1) SA98190565B1 (fr)
TR (1) TR200000649T2 (fr)
TW (1) TW552139B (fr)
UY (1) UY25172A1 (fr)
WO (1) WO1999012561A2 (fr)
ZA (1) ZA988030B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2873A1 (fr) 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
EP1295605A3 (fr) * 1998-08-19 2003-10-29 Eli Lilly And Company Procédé permettant d'augmenter la solidité et la rigidité osseuse et de réduire des fractures
EP1769804B1 (fr) * 1998-08-19 2012-09-19 Eli Lilly And Company hPTH(1-34) pour son utilisation dans la prévention ou la sévérité de fractures osseuses chez le mâle humain
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
CA2245903A1 (fr) * 1998-09-28 2000-03-28 Mcgill University Utilisation de pex dans le traitement des maladies osseuses metaboliques
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6675048B2 (en) * 2000-05-08 2004-01-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
US6393328B1 (en) * 2000-05-08 2002-05-21 International Rehabilitative Sciences, Inc. Multi-functional portable electro-medical device
US6560487B1 (en) 2000-05-08 2003-05-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
EP1531855A4 (fr) * 2002-01-10 2009-07-22 Osteotrophin Llc Traitement des affections osseuses avec des medicaments anabolisants du squelette
AU2003272814A1 (en) 2003-10-02 2005-05-19 Ibrahim Al-Habdan Peptide for promoting healing of fractures
KR20070067136A (ko) * 2004-10-08 2007-06-27 포베스 메디-테크 (리서치) 인코포레이티드 혈관작용성 장내 폴리펩티드 제약
CA2628945A1 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
WO2007133580A2 (fr) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Procédés permettant une stimulation hématopoïétique
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CN102274492B (zh) 2006-10-03 2014-11-26 半径健康公司 骨合成代谢蛋白质的药物递送方法
EP1961765A1 (fr) * 2006-12-08 2008-08-27 Zealand Pharma A/S Peptides PTH tronqués à formation cyclique
JP5564167B2 (ja) * 2008-05-22 2014-07-30 日本たばこ産業株式会社 苦味マスキング剤及び苦味低減方法
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2411038B1 (fr) 2009-03-27 2016-12-28 Van Andel Research Institute Peptides de l'hormone parathyroïdienne et peptides de la protéine apparentée à l'hormone parathyroïdienne ainsi que des procédés d'utilisation
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
CN104146961B (zh) * 2014-07-04 2018-02-27 深圳职业技术学院 一种薄膜蒸发法制备载细胞因子和骨蛋白微球的方法
EP4039253A1 (fr) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Procédés de traitement du cancer
WO2017007777A2 (fr) * 2015-07-06 2017-01-12 Zhengxin Dong Nouvelles formulations d'un analogue de pthrp
EP3998061A1 (fr) 2016-04-18 2022-05-18 Radius Health, Inc. Formulations d'abaloparatide, patchs transdermiques correspondants et leurs utilisations
EP3565542B1 (fr) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Formes polymorphes de rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態
EP4027899A4 (fr) * 2019-09-12 2023-08-16 Radius Health, Inc. Procédés d'amélioration de la fusion vertébrale au moyen d'abaloparatide
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
WO2022149066A1 (fr) * 2021-01-05 2022-07-14 Radius Health, Inc. Traitement de longues fractures osseuses à l'aide d'abaloparatide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
WO1995002610A1 (fr) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogues de la parathormone et peptide apparente a la parathormone: synthese et utilisation pour le traitement de l'osteoporose
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
JPH08310965A (ja) * 1995-05-16 1996-11-26 Chugai Pharmaceut Co Ltd 骨癒合促進剤
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
HUP0004560A2 (hu) 2001-04-28
KR100679778B1 (ko) 2007-02-07
ZA988030B (en) 1999-03-09
NZ502970A (en) 2002-03-01
AR015435A1 (es) 2001-05-02
RU2224539C2 (ru) 2004-02-27
KR20010023795A (ko) 2001-03-26
HU226866B1 (en) 2009-12-28
EP1005359A2 (fr) 2000-06-07
HRP20000109A2 (en) 2001-02-28
HK1030753A1 (en) 2001-05-18
NO20001195L (no) 2000-03-08
RS49707B (sr) 2007-12-31
DE69830591D1 (de) 2005-07-21
TR200000649T2 (tr) 2000-09-21
PE117399A1 (es) 1999-11-20
WO1999012561A9 (fr) 2000-03-16
CN1210059C (zh) 2005-07-13
IL134719A (en) 2010-04-29
MY121291A (en) 2006-01-28
SA98190565B1 (ar) 2006-07-30
CA2302255C (fr) 2011-11-08
CZ298701B6 (cs) 2007-12-27
NO323740B1 (no) 2007-07-02
ES2244090T3 (es) 2005-12-01
US20020077281A1 (en) 2002-06-20
CZ2000862A3 (cs) 2000-09-13
AU9740698A (en) 1999-03-29
CA2302255A1 (fr) 1999-03-18
NO20001195D0 (no) 2000-03-08
CN1269726A (zh) 2000-10-11
ATE297754T1 (de) 2005-07-15
US6583114B2 (en) 2003-06-24
IL134719A0 (en) 2001-04-30
PL195703B1 (pl) 2007-10-31
WO1999012561A2 (fr) 1999-03-18
WO1999012561A3 (fr) 1999-05-14
EP1005359B1 (fr) 2005-06-15
DE69830591T2 (de) 2006-05-04
PL339449A1 (en) 2000-12-18
CO4890856A1 (es) 2000-02-28
JP2002509854A (ja) 2002-04-02
AU752925B2 (en) 2002-10-03
YU12700A (sh) 2004-09-03
UY25172A1 (es) 2001-01-31
TW552139B (en) 2003-09-11
HUP0004560A3 (en) 2005-11-28
BR9812068A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
MA26545A1 (fr) Procedes de cicatrisation des os
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
DE69839989D1 (de) Bildgesteuertes chirurgisches system
DE29606468U1 (de) Wirbelsäulenfixateur
FR2751202B1 (fr) Implant squelettique
DE69623374T2 (de) Intramedulläre Knochenstütze
DE59710521D1 (de) Knochenfixationsvorrichtung
DK0980250T3 (da) Planteekstrakter til behandling af forøget knogleresorption
DE69824227D1 (de) Wärmebehandlungsanlage
NO983364L (no) Konsensusproteiner
DE29720449U1 (de) Operationseinrichtung
FR2759576B1 (fr) Implant de sclero-keratectomie pre-descemetique
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
DE69814070T2 (de) Sterilisationsverfahren
CY2007022I1 (el) Μεθοδος παρεμποδισης της απορροφησης οστων
FR2778085B1 (fr) Implant squelettique
DE69807225D1 (de) Vliesstoffbehandlung
DE29703971U1 (de) Knochenprothese
DE29715168U1 (de) Chirurgisches Endoskop
BR9610382A (pt) Composição de tratamento do cableo
DE29600369U1 (de) Chirurgische Knochenmühle
DE59602924D1 (de) Knochenraspel
DE29611740U1 (de) Orthopädische Einlegesohle
DE29820434U1 (de) System zum Fixieren von Knochenfrakturen
DE29509010U1 (de) Knochenmarkraspel